DNA Biosensors for Toxin Detection with Yi Lu | Beckman Institute

Added:

Practical Limitations of DNA Biosensors and the Reliability of Established Analytical Standards

While DNA-based biosensors offer rapid, on-site detection, they face significant practical challenges that limit their real-world deployment compared to established analytical methods. A major criticism is their vulnerability to degradation by nucleases present in environmental and biological samples, as well as their high sensitivity to fluctuations in pH, temperature, and ionic strength, which can alter DNA conformation and lead to false results. Furthermore, complex sample matrices often cause signal interference, reducing accuracy. Opponents and traditional analytical chemists argue that sophisticated laboratory-based methods, such as Inductively Coupled Plasma Mass Spectrometry (ICP-MS) for heavy metals and Liquid Chromatography-Mass Spectrometry (LC-MS) for toxins, remain the gold standard due to their superior precision, lower detection limits, and robustness. Additionally, emerging synthetic alternatives like Molecularly Imprinted Polymers (MIPs) provide a more stable, durable, and cost-effective solution for field testing without the biological fragility of nucleic acids.

Basic structure and hybridization of nucleic acids (DNA/RNA), including the concepts of synthetic aptamers and catalytic DNA (DNAzymes).
Fundamentals of biosensor architecture, specifically the distinction between bioreceptors (recognition elements) and transducers.
Optical properties of nanomaterials, particularly localized surface plasmon resonance (LSPR) in gold nanoparticles and how aggregation states induce color changes.
Basic principles of fluorescence spectroscopy, including excitation, emission, and how portable fluorometers quantify signal intensity.
The SELEX (Systematic Evolution of Ligands by Exponential Enrichment) process used to engineer custom DNAzymes and aptamers for novel target analytes.
Integration of DNA biosensors into paper-based microfluidics and 'lab-on-a-chip' systems for automated point-of-care (POC) testing.
Methods for overcoming matrix interference and non-specific binding when analyzing complex real-world samples like soil, blood, or wastewater.
Commercialization and regulatory pathways for environmental and medical diagnostic devices, including stability testing and scale-up manufacturing.
13.3K views115likes7:44@BeckmanIllinoisOriginal Release: 2010-09-24

DNA-based biosensors utilize gold nanoparticles and DNA strands to detect toxins such as lead, uranium, and drugs like cocaine through colorimetric or fluorescent changes; when target molecules bind to the DNA, they cause structural changes that either disrupt the DNA-gold nanoparticle assembly (producing visible color changes) or cleave the DNA to release fluorescent signals, enabling rapid, portable detection of environmental contaminants and disease markers.